Introduction: Immunological Reviews volume 290.
- Published in:
- Immunological Reviews, 2019, v. 290, n. 1, p. 4, doi. 10.1111/imr.12797
- By:
- Publication type:
- Article
Works matching IS 01052896 AND DT 2019 AND VI 290 AND IP 1
Results: 10
1
2
Immunobiology of chimeric antigen receptor T cells and novel designs.
- Published in:
- Immunological Reviews, 2019, v. 290, n. 1, p. 100, doi. 10.1111/imr.12794
- By:
- Publication type:
- Article
3
Cellular therapy: Adoptive immunotherapy with expanded natural killer cells.
- Published in:
- Immunological Reviews, 2019, v. 290, n. 1, p. 85, doi. 10.1111/imr.12793
- By:
- Publication type:
- Article
4
Updates on CAR T‐cell therapy in B‐cell malignancies.
- Published in:
- Immunological Reviews, 2019, v. 290, n. 1, p. 39, doi. 10.1111/imr.12774
- By:
- Publication type:
- Article
5
CAR T cells for brain tumors: Lessons learned and road ahead.
- Published in:
- Immunological Reviews, 2019, v. 290, n. 1, p. 60, doi. 10.1111/imr.12773
- By:
- Publication type:
- Article
6
T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance.
- Published in:
- Immunological Reviews, 2019, v. 290, n. 1, p. 127, doi. 10.1111/imr.12772
- By:
- Publication type:
- Article
7
Cellular therapy: Immune‐related complications.
- Published in:
- Immunological Reviews, 2019, v. 290, n. 1, p. 114, doi. 10.1111/imr.12768
- By:
- Publication type:
- Article
8
Immune checkpoint inhibitors: The linchpins of modern immunotherapy.
- Published in:
- Immunological Reviews, 2019, v. 290, n. 1, p. 6, doi. 10.1111/imr.12766
- By:
- Publication type:
- Article
9
STING pathway agonism as a cancer therapeutic.
- Published in:
- Immunological Reviews, 2019, v. 290, n. 1, p. 24, doi. 10.1111/imr.12765
- By:
- Publication type:
- Article
10
Issue Information.
- Published in:
- Immunological Reviews, 2019, v. 290, n. 1, p. 1, doi. 10.1111/imr.12679
- Publication type:
- Article